Last reviewed · How we verify
CJ Plasma Solution A Injection
CJ Plasma Solution A is a plasma-derived therapeutic that replenishes coagulation factors and other plasma proteins to support hemostasis and tissue repair.
CJ Plasma Solution A is a plasma-derived therapeutic that replenishes coagulation factors and other plasma proteins to support hemostasis and tissue repair. Used for Coagulopathy and hemostatic support (Phase 3 indication under investigation).
At a glance
| Generic name | CJ Plasma Solution A Injection |
|---|---|
| Sponsor | Seoul National University Hospital |
| Drug class | Plasma derivative |
| Modality | Small molecule |
| Therapeutic area | Hematology / Critical Care |
| Phase | Phase 3 |
Mechanism of action
As a plasma-based injectable, this solution contains multiple coagulation factors, albumin, and immunoglobulins that work synergistically to restore hemostatic function and provide nutritional/immunological support. The exact composition and mechanism are proprietary to Seoul National University Hospital, but plasma solutions are typically used to correct coagulopathy, replace lost blood volume, and support wound healing or recovery in critical conditions.
Approved indications
- Coagulopathy and hemostatic support (Phase 3 indication under investigation)
Common side effects
- Transfusion-related acute lung injury (TRALI)
- Allergic reaction
- Infection risk (pathogen transmission)
- Volume overload
Key clinical trials
- The Effect of Balanced Crystalloid Versus 5% Albumin on Endothelial Glycocalyx Degradation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery (PHASE4)
- Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial) (PHASE3)
- A Gray Zone Approach to Stroke Volume Variation Derived From NICOM
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CJ Plasma Solution A Injection CI brief — competitive landscape report
- CJ Plasma Solution A Injection updates RSS · CI watch RSS
- Seoul National University Hospital portfolio CI